AXIOM INVESTORS LLC /DE

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1109147 GREENWICH, CT

Position in SUPN

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$8,476,022

+$3,198,628 QoQ

Shares Held

163,978

+54.4% QoQ

Ownership

0.283%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 78.72275549159033.ToString("F0")% Shared 0.ToString("F0")% None 21.277244508409666.ToString("F0")%

Healthcare · as of Mar 31, 2026

AXIOM INVESTORS LLC /DE holds $8,953,370 across 2 Drug Manufacturers - Specialty & Generic names. SUPN ranks #1 (94.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	SUPN	Supernus Pharmaceuticals, Inc. This page	163,978	$8,476,022
2	UTHR	UNITED THERAPEUTICS Corp	805	$477,348

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,476,022	163,978	+54.4%	Shares	Sole	2026-05-14
2025-12-31	$5,277,394	106,185	+1.5%	Shares	Sole	2026-02-11
2025-09-30	$5,000,554	104,636	+86.5%	Shares	Sole	2025-11-14
2025-06-30	$1,768,744	56,115	+3.2%	Shares	Sole	2025-08-07
2025-03-31	$1,780,781	54,375	-22.2%	Shares	Sole	2025-05-16
2024-12-31	$2,527,439	69,896	+38.9%	Shares	Sole	2025-02-12
2024-09-30	$1,569,445	50,335	-8.2%	Shares	Sole	2024-11-12
2024-06-30	$1,467,505	54,860	+1.2%	Shares	Sole	2024-08-13
2024-03-31	$1,849,955	54,235	+11.9%	Shares	Sole	2024-05-13
2023-12-31	$1,402,287	48,455	+255.9%	Shares	Sole	2024-02-12
2023-09-30	$375,365	13,615	-43.0%	Shares	Sole	2023-11-13
2023-06-30	$718,434	23,900	-6.6%	Shares	Sole	2023-08-10
2023-03-31	$927,306	25,595	+26.5%	Shares	Sole	2023-05-12
2022-12-31	$721,960	20,240	—	Shares	Sole	2023-02-09
No filing history on record for this holder in this stock.